Latest University of Texas Health Science Center at Houston Stories
New test less invasive, more comfortable way to diagnose this serious conditionA computer scientist from the University of Houston and a doctor of sleep medicine at the University of Texas Health Science Center at Houston have teamed up to create a new, less invasive method of diagnosing sleep apnea. Their findings appear in the November issue of the journal Sleep.Sleep apnea is serious disorder that causes a person to momentarily stop breathing while they sleep. These pauses in breathing can...
Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.Priapism is a condition of persistent painful penile erection in the absence of sexual desire. It is highly associated with sickle cell disease, leukemia and other blood disorders. It can also result from vasoactive...
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding. Researchers used a mouse model to generate the antibodies. The report...
In a development that could lead to a novel approach to the treatment of a devastating lung disease, biochemists at The University of Texas Health Science Center at Houston report they are the first to link the osteopontin (OPN) protein to chronic obstructive pulmonary disease (COPD). Findings appear online and will be in the January 2010 print issue of The FASEB Journal, the journal of The Federation of American Societies for Experimental Biology.More than 12 million Americans are currently...
New research at The University of Texas Health Science Center at Houston suggests that ancient Chinese herbal formulas used primarily for cardiovascular indications including heart disease may produce large amounts of artery-widening nitric oxide. Findings of the preclinical study by scientists in the university's Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) appear in the Sept. 15 print issue of the journal Free Radical Biology &...
We've all seen video of astronauts drifting and gliding gracefully around inside the International Space Station like fish in a fishbowl. It looks so relaxing. But as enjoyable as it appears to be, there's a down side to all that freefalling (1)."When astronauts land back on Earth after a long time in space, not only is their vestibular system mixed up and their kinesthetic sense thrown off," says Dr. Benjamin Levine of the University of Texas Southwestern Medical Center, "but...
The aggressiveness of tumors and their susceptibility to chemotherapy may become easier to predict based on a mathematical model developed at The University of Texas Health Science Center at Houston.In spite of extensive experimental and clinical studies, the process of cancer growth is not well understood. Tumors are complex systems, with changes at the molecular and cellular levels influencing shape and behavior in sometimes unpredictable ways. New research by a scientist in mathematical...
HOUSTON "“"“ New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or "water pill" outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine.About one in three adults in the United States has high blood pressure, which, according to the National Heart...
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine's Advance Online Publication March 1. Their findings resulted from more than 6 years of research funded by the National Institutes of Health (NIH).Bacille Calmette-Guérin (BCG) provides only partial protection...
Positron Corporation (OTC: POSC) (the "Company") announced today that it has acquired an exclusive license to a coronary disease reversal and prevention practice management program created by K. Lance Gould, M.D. and the University of Texas Health Science Center at Houston. "We are grateful to the University of Texas Health Science Center at Houston and Dr. Gould for selecting Positron Corporation as the exclusive licensee of their heart disease management product", stated Joe Oliverio,...
